Abstract |
Unresolved inflammation is a major contributor to the development of heart failure following myocardial infarction (MI). Pro-resolving lipid mediators, such as resolvins (e.g. RvD1), are biosynthesized endogenously. The role of RvD1 in resolving post-MI inflammation has not been elucidated due to its unstable nature. Here, we have tested the role for two forms of RvD1, after incorporation into liposomes (Lipo-RvD1) and its free acid form (RvD1) in the left ventricle (LV) and splenic remodeling post-MI. 8 to 12-week old male, C57BL/6J-mice were subjected to coronary artery ligation and Lipo-RvD1 or RvD1 (3 μg/kg/day) was injected 3h post-MI for day (d)1 or until d5. No-MI mice and saline-injected MI mice served as controls. RvD1 injected groups showed improved fractional shortening post-MI; preserving transient changes in the splenic reservoir compared to MI-saline. RvD1-groups showed an early exit of neutrophils from LV and spleen at d5 post-MI with an increased expression of lipoxin A4 receptor (ALX; synonym formyl peptide receptor; FPR2) compared to the MI-saline group. The levels of pro-resolving mediators RvD1, RvD2, Maresin 1 (MaR1) and Lipoxin A4 ( LXA4) were increased in spleens from RvD1 injected mice at d5 post-MI. RvD1 administration reduced macrophage density, ccr5 and cxcl5 levels at d5 post-MI compared to saline injected mice (both, p < 0.05). Increased transcripts of mrc-1, arg-1 and Ym-1 (all, p < 0.05) suggest macrophage-mediated clearance of necrotic cells in RvD1-groups. RvD1 reduced the pro-fibrotic genes (colla1, coll2a1 and tnc (all; p < 0.05)) and decreased collagen deposition, thereby reducing post-MI fibrosis and thus stabilizing the extracellular matrix. In summary, RvD1 and Lipo-RvD1 promote the resolution of acute inflammation initiated by MI, thereby delaying the onset of heart failure.
|
Authors | Vasundhara Kain, Kevin A Ingle, Romain A Colas, Jesmond Dalli, Sumanth D Prabhu, Charles N Serhan, Medha Joshi, Ganesh V Halade |
Journal | Journal of molecular and cellular cardiology
(J Mol Cell Cardiol)
Vol. 84
Pg. 24-35
(Jul 2015)
ISSN: 1095-8584 [Electronic] England |
PMID | 25870158
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Receptors, Formyl Peptide
- formyl peptide receptor 2, mouse
- resolvin D1
- Docosahexaenoic Acids
- Collagen
- Arachidonate 5-Lipoxygenase
- Prostaglandin-Endoperoxide Synthases
|
Topics |
- Animals
- Arachidonate 5-Lipoxygenase
(metabolism)
- Cardiomegaly
(complications, diagnostic imaging, drug therapy, physiopathology)
- Cell Count
- Cell Polarity
(drug effects)
- Collagen
(metabolism)
- Docosahexaenoic Acids
(chemistry, pharmacology, therapeutic use)
- Extracellular Matrix
(drug effects, genetics)
- Heart Ventricles
(drug effects, physiopathology)
- Inflammation
(complications, drug therapy)
- Macrophages
(drug effects, metabolism)
- Male
- Mice, Inbred C57BL
- Myocardial Infarction
(complications, diagnostic imaging, drug therapy, physiopathology)
- Neutrophil Infiltration
(drug effects)
- Prostaglandin-Endoperoxide Synthases
(metabolism)
- Pulmonary Edema
(complications, drug therapy, physiopathology)
- Receptors, Formyl Peptide
(metabolism)
- Spleen
(drug effects, pathology)
- Ultrasonography
- Ventricular Function
(drug effects)
- Ventricular Remodeling
(drug effects)
|